research Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design February 2024 Potential new drugs for treating PCOS were identified.
research De novo designed bifunctional proteins for targeted protein degradation December 2025 Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.
research De Novo Design of Anti-Aging Peptides October 2025 New peptides can delay aging and improve cell function.
research Chemistry42: An AI-Driven Platform for Molecular Design and Optimization 180 citations , February 2023 in “Journal of Chemical Information and Modeling” Chemistry42 effectively creates and optimizes new molecules for drug discovery.
research Characterisation of Myotonic Dystrophy type I cell models and drug evaluation by a cell- based quantification platform. November 2024 in “Communities in ADDI (University of the Basque Country)” Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.